Global Personalized Cell Therapy Market, By Applications (Platelet Transfusions, Bone Marrow Transplantation, Packed Red Cell Transfusions, Organ Transplantation), Therapeutic Area (Cardiovascular Diseases, Neurological Disorders, Inflammatory Diseases, Diabetes, Cancer), and Geography - Insights, Opportunity Analysis, and Industry Forecast till 2025

Personalized Cell Therapy – Personalizing Treatment for Improved Outcomes

Individualized treatment for various diseases such as cancer and autoimmune diseases by injecting living cells into a patient’s body is known as personalized cell therapy. Various types of living cells such as mature and immature solid tissue cells, adult stem cells, blood and bone marrow cells, and embryonic stem cells are used for personalized cell therapy. It has various applications such as platelet transfusions, bone marrow transplantation, whole blood transfusions, packed red cell transfusions, and organ transplantation. Due to its ability to treat various diseases, personalized cell therapy has received extensive acceptance among surgeons and patients. It is used to treat neurological diseases such as Parkinson’s disease and amyotrophic lateral sclerosis, spinal cord injuries, diabetes, and cancer.

According to Centre for Disease Control (CDC), globally, around 14.1 million people were diagnosed with cancer in 2012, leading to 8.2 million fatalities. It is projected that around 19.3 million new cancer cases will be diagnosed by 2025. Furthermore, as per International Diabetes Federation (IDF), in 2015, over 415 million people suffered from diabetes and this number is expected to reach 642 million by 2040. It is expected that rising prevalence of chronic diseases and rapid spurt in incidence rate of cancer cases will fuel the growth of the global personalized cell therapy market.

The other major factor driving the growth of personalized cell therapy market is increasing government initiatives and funding for stem cell research. For example, in 2015, the National Institutes of Health invested around US$ 1,429 million in stem cell research, as stem cells research offers great potential for better understanding of human development it is expected that this factor will fuel growth of the personalized cell therapy market in the near future.

Increase in development of personalized cell therapy products along with high prevalence of lifestyle diseases driving the growth of personalized cell therapy market in developed regions

Better healthcare amenities along with high adoption rate of new technology for the treatment of cancer in the developed region is expected to boost overall sales of autologous cell therapy products in regions such as North America and Europe. There are over 200 companies engaged in development of personalized cell therapy products in the U.S. alone.

The personalized cell therapy market is expected to gain traction in Europe and Asia-Pacific region, which is supported by improvement in healthcare facilities and growing awareness about the personalized cell therapy in emerging economies such as India and China.

As per American Diabetes Association, prevalence of diabetes has nearly doubled since 1980, from 4.7% to 8.7% in 2014. Furthermore, according to Centers for Disease Control and Prevention (CDC), around 117 million people of U.S. had one or more chronic health conditions as of 2012, also in 2014 around 29.1 million people were suffering from diabetes in the U.S.

The global personalized cell therapy market was valued at US$ 3,536.2 million in 2016 and is expected to witness a robust CAGR of 25.3% during the forecast period (2017 – 2024).

Global Personalized Cell Therapy Market Analysis, By Region - 2016

personalized cell therapy market

Source: Coherent Market Insights

Increased prevalence of inflammatory bowel disease is expected to create significant market opportunity for players in the personalized cell therapy market

Currently, except of few therapies practiced to reduce inflammation and inhibit immune response, there are no curative therapy for inflammatory bowel disease (IBD). As drug therapy is not always effective, research experts have discovered special cells in bone marrow that can be developed into injectable cell therapy to treat IBD.

According to study conducted by Wake Forest School of Medicine in 2016, there are over 1 million people in the U.S. suffering from IBD, which is caused by recurrent diarrhea and is characterized by persistent abdominal pain. IBD comprises various medical conditions such as ulcerative colitis and Crohn's disease. In these diseases, the intestines get damaged and can become red and swollen ulcers. This inadvertently creates a highly conducive environment for growth of the global personalized cell therapy market.

Increased economic burden due to neurological disorders expected to fuel the growth in personalized cell therapy market

In complicated neurological disorders such as multiple sclerosis, stroke or spinal cord injuries, scientist claim that stem cells treatment may be the best option or choice of cure. Stem cells can be replaced with damaged cells or the cells, which are highly mitigated to immune responses even in the central nervous system. There are no successful clinical trials so far, as the scientists are facing hurdles in stem cell therapies, however, the use of embryonic stem cells is still a moral issue in most of the regions, obtaining adult stem cells is difficult to collect or tough to be expanded in a therapeutically sufficient amount.

There are several studies conducted on stem cell or personalized cell therapy to treat neurological disorder and spinal cord injury. For instance, in September 2016, MAPFRE Foundation, announced first clinical trial results on personalized cell therapy in patients with complete and chronic spinal cord injury. The study was to implant mesenchymal stem cells, which can create different types of tissue to treat spinal cord injury. The results obtained, explains the improvement in sensitivity and spasticity (muscle stiffness) in all cases, bowel improvement and bladder control in over 80% of patients. Thus, players in the global personalized cell therapy market are focusing efforts to cater to this large target audience.

Some of the major companies in personalized cell therapy market are Cytori Therapeutics Inc., Bellicum Pharmaceuticals, Inc., Saneron CCEL Therapeutics, Inc., MolMed S.p.A. and Vericel Corporation.

The patient-tailored therapies for the treatment of variety of disease are known as personalized cell therapy. The personalized cell therapy is based on genomic profile, and disease prevalence/severity and the drug developed by this therapy target the patients who matches the specific disease physiopathology and/or patient characteristics.

The personalized cell therapy is mainly developed for the treatment of high unmet need disease such as cancer, also it comprises drugs for treatment of other diseases such as autoimmune disease, cardiovascular, neurologic and inflammatory disease.

Personalized cell therapy also finds application in the area of platelet transfusions, packed red cell transfusions, bone marrow transplantation and in organ transplantation.

Personalized Cell Therapy Market Dynamics

The continuous development in science and technology sector has led to development of various novel individualized drugs, which would fuel growth of the personalized cell therapy market in the near future. Personalized cell therapy favors the accurate diagnosis of the disease and active monitoring of the treatment response and disease progression. This allows for early detection of diseases at molecular level and enables the physician to prepare the treatment regime for the specific patient requirement. This helps the patient recover at a significant pace and also helps avoid any major side effects, as individualized cell therapy is based on patient’s genomics.

Newly introduced procedures and techniques are expected to favor increase in adoption rate for personalized cell therapy in the near future. New ventures in the biologics industry are expected to be a major push for the market to grow, for instance, a high demand for biological compounds is influencing organizations to manufacture products using the biopharmaceutical process, which is further administered through injections.

Large untapped markets in emerging economies can be capitalized upon through favorable product pricing, which further can facilitate the increase in number of procedures worldwide. Also, as the manufacturing cost requirement is low in emerging economies as compare to developed countries this will help to grow the market in emerging economies such as India and China.

Market Taxonomy

This report segments the global personalized cell therapy market on the basis of applications, therapeutic area and geography. On the basis of application, the market is categorized into Platelet Transfusions, Bone Marrow Transplantation, Packed Red Cell Transfusions and Organ Transplantation. Among these applications, Platelet Transfusions segment dominate the personalized cell therapy market. On the basis of therapeutic area, the market is divided into Cardiovascular Diseases, Neurological Disorders, Inflammatory Diseases, Diabetes and Cancer. On the basis of geography, the market is divided into 6 Regions. Among all regions, North America dominated the personalized cell therapy market, as more than 200 companies engaged in development of personalized cell therapy products in U.S. Also, better healthcare amenities and high prevalence of cancer in the region is expected to boost overall sales of autologous cell therapy products.

Key features of the study:

  • This report provides in-depth analysis of the personalized cell therapy market and provides market size (US$ Mn) and Cumulative Annual Growth Rate (CAGR) (%) for the forecast period (2017–2024)
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, new product launches or approval, pipeline drugs, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global personalized cell therapy market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions with respect to their future product launch, market expansion, and marketing tactics
  • The global personalized cell therapy market report caters to various stakeholders in this industry, including investors, product developers, distributors, healthcare companies, research institutes, CROs, medical device companies, new entrants, and financial analysts
  • Stakeholders would greatly benefit in decision making through the various strategy matrices used in analyzing the personalized cell therapy market

Detailed Segmentation:

  • Global Personalized Cell Therapy Market, By Applications:
    • Platelet Transfusions
    • Bone Marrow Transplantation
    • Packed Red Cell Transfusions
    • Organ Transplantation
  • Global Personalized Cell Therapy Market, By Therapeutic Area:
    • Cardiovascular Diseases
    • Neurological Disorders
    • Inflammatory Diseases
    • Diabetes
    • Cancer
  • Global Personalized Cell Therapy Market, By Geography:
    • North America
      • North America Personalized Cell Therapy Market, By Applications:
        • Platelet Transfusions
        • Bone Marrow Transplantation
        • Packed Red Cell Transfusions
        • Organ Transplantation
      • North America Personalized Cell Therapy Market, By Therapeutic Area:
        • Cardiovascular Diseases
        • Neurological Disorders
        • Inflammatory Diseases
        • Diabetes
        • Cancer
      • North America Personalized Cell Therapy Market, By Country:
        • U.S.
        • Canada
    • Europe
      • Europe Personalized Cell Therapy Market, By Applications:
        • Platelet Transfusions
        • Bone Marrow Transplantation
        • Packed Red Cell Transfusions
        • Organ Transplantation
      • Europe Personalized Cell Therapy Market, By Therapeutic Area:
        • Cardiovascular Diseases
        • Neurological Disorders
        • Inflammatory Diseases
        • Diabetes
        • Cancer
      • Europe Personalized Cell Therapy Market, By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia-Pacific
      • Asia-Pacific Personalized Cell Therapy Market, By Applications:
        • Platelet Transfusions
        • Bone Marrow Transplantation
        • Packed Red Cell Transfusions
        • Organ Transplantation
      • Asia-Pacific Personalized Cell Therapy Market, By Therapeutic Area:
        • Cardiovascular Diseases
        • Neurological Disorders
        • Inflammatory Diseases
        • Diabetes
        • Cancer
      • Asia-Pacific Personalized Cell Therapy Market, By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia-Pacific
    • Latin America
      • Latin America Personalized Cell Therapy Market, By Applications:
        • Platelet Transfusions
        • Bone Marrow Transplantation
        • Packed Red Cell Transfusions
        • Organ Transplantation
      • Latin America Personalized Cell Therapy Market, By Therapeutic Area:
        • Cardiovascular Diseases
        • Neurological Disorders
        • Inflammatory Diseases
        • Diabetes
        • Cancer
      • Latin America Personalized Cell Therapy Market, By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Middle East Personalized Cell Therapy Market, By Applications:
        • Platelet Transfusions
        • Bone Marrow Transplantation
        • Packed Red Cell Transfusions
        • Organ Transplantation
      • Middle East Personalized Cell Therapy Market, By Therapeutic Area:
        • Cardiovascular Diseases
        • Neurological Disorders
        • Inflammatory Diseases
        • Diabetes
        • Cancer
      • Middle East Personalized Cell Therapy Market, By Country:
        • GCC
        • Israel
        • Rest of Middle-East
    • Africa
      • Africa Personalized Cell Therapy Market, By Applications:
        • Platelet Transfusions
        • Bone Marrow Transplantation
        • Packed Red Cell Transfusions
        • Organ Transplantation
      • Africa Personalized Cell Therapy Market, By Therapeutic Area:
        • Cardiovascular Diseases
        • Neurological Disorders
        • Inflammatory Diseases
        • Diabetes
        • Cancer
      • Africa Personalized Cell Therapy Market, By Country:
        • North Africa
        • Central Africa
        • South Africa
  • Company Profiles
    • Cytori Therapeutics Inc. *
      • Company Overview
      • Product Portfolio
      • Strategies Presence
      • Key Developments
    • Bellicum Pharmaceuticals, Inc.
    • Saneron CCEL Therapeutics, Inc.
    • MolMed S.p.A.
    • Vericel Corporation

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet By Different Segments
      • Market Snippet By Applications
      • Market Snippet By Therapeutic Area
      • Market Snippet By Geography
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers, Challenges, and Recommendations
      • Regulatory Scenario
      • Market Trends
      • Market Opportunities
      • Merger and Acquisitions
      • Key Developments
      • Approved Products and Industry Disruptive Force (CAR-T Cell Therapy)
  4. Global Personalized Cell Therapy Market, By Applications, 2014 - 2024 (US$ Million)
    • Introduction
      • Market Share Analysis, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, 2014 - 2024
      • Segment Trends
    • Platelet Transfusions
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
    • Bone Marrow Transplantation
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
    • Packed Red Cell Transfusions
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
    • Organ Transplantation
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
  5. Global Personalized Cell Therapy Market, By Therapeutic Area, 2014 - 2024 (US$ Million)
    • Introduction
      • Market Share Analysis, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, 2014 - 2024
      • Segment Trends
    • Cardiovascular Diseases
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
    • Neurological Disorders
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
    • Inflammatory Diseases
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
    • Diabetes
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
    • Cancer
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
  6. Global Personalized Cell Therapy Market, By Geography, 2014 - 2024 (US$ Million)
    • Introduction
      • Market Share Analysis, By Geography, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, 2014 – 2024
      • Regional Trends
      • Regional Attractiveness Index
    • North America
      • Introduction
      • Market Share Analysis, By Country, 2015 and 2024 (%)
      • Market Size and Forecast, and Y-o-Y Growth, 2014-2024, (USD Million)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Share Analysis, By Country, 2015 and 2024 (%)
      • Market Size and Forecast, and Y-o-Y Growth, 2014-2024, (USD Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Share Analysis, By Country, 2015 and 2024 (%)
      • Market Size and Forecast, and Y-o-Y Growth, 2014-2024, (USD Million)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Share Analysis, By Country, 2015 and 2024 (%)
      • Market Size and Forecast, and Y-o-Y Growth, 2014-2024, (USD Million)
        • Brazil
        • Argentina
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Share Analysis, By Country, 2015 and 2024 (%)
      • Market Size and Forecast, and Y-o-Y Growth, 2014-2024, (USD Million)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Share Analysis, By Country, 2015 and 2024 (%)
      • Market Size and Forecast, and Y-o-Y Growth, 2014-2024, (USD Million)
        • North Africa
        • Central Africa
        • South Africa
  7. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Cytori Therapeutics Inc.
        • Company Highlights
        • Product Portfolio
        • Strategic Presence
        • Key Developments
      • Bellicum Pharmaceuticals, Inc.
        • Company Highlights
        • Product Portfolio
        • Strategic Presence
        • Key Developments
      • Saneron CCEL Therapeutics, Inc.
        • Company Highlights
        • Product Portfolio
        • Strategic Presence
        • Key Developments
      • MolMed S.p.A.
        • Company Highlights
        • Product Portfolio
        • Strategic Presence
        • Key Developments
      • Vericel Corporation
        • Company Highlights
        • Product Portfolio
        • Strategic Presence
        • Key Developments
    • Analyst Views
  8. Section
    • Research Methodology
    • About us and Services

*Browse 21 market data tables and 25 figures on "Personalized Cell Therapy Market - Global forecast to 2024”.  

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.